# Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients

> **NCT01075438** · — · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Ataxia Telangiectasia

## Interventions

- **BIOLOGICAL:** Prevenar® (7-valent pneumococcal conjugate vaccine)
- **BIOLOGICAL:** Pneumovax® (pneumococcal polysaccharide vaccine)

## Key facts

- **NCT ID:** NCT01075438
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-03
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01075438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01075438, "Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01075438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*